Multi Control Cardiac Marker
- UID
- IMP/IVD/2022/000117_ec3a3f46c1fcc768610fd4332baff285_2f771dd7254119863cf60571ba01d7ca
- Device class
- Class C
- Brand name
- eCLIA
- Approving authority
- CDSCO
- Product information
- It’s suitable for quality control of Lifotronic electrochemiluminescence immunoassay reagents Troponin I (eCLIA), Myoglobin (eCLIA), Creatine Kinase MB (eCLIA), and N-terminal pro B-type Natriuretic Peptide (eCLIA) on eCL8000 series Automated ECL Analyzer
Multi Control Cardiac Marker is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000117_ec3a3f46c1fcc768610fd4332baff285_2f771dd7254119863cf60571ba01d7ca. This device is marketed under the brand name eCLIA. The license holder is Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED), and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.